protein degradation Archives -

Bristol-Myers Squibb’s Celgene unit has clearly been impressed by progress in its four-year-old alliance with Evotec on protein

BMS pays $200m to expand Evotec alliance on protein degraders

https://pharmaphorum.com/news/bms-pays-200m-to-expand-evotec-alliance-on-protein-degraders/

In only its second year of operations, Cambridge, UK startup Dunad Therapeutics has already attracted a big pharma

UK biotech Dunad inks $1.3bn Novartis deal for its protein degraders

https://pharmaphorum.com/news/uk-biotech-dunad-inks-1-3bn-novartis-deal-for-its-protein-degraders/

Eli Lilly has bolstered its position the fast-emerging area of protein degrader drugs, agreeing a $1.6 billion-plus deal

Lilly taps Lycia for protein degrader tech in $1.6bn deal

https://pharmaphorum.com/news/lilly-taps-lycia-for-protein-degrader-tech-in-1-6bn-deal/

Pfizer has pledged a whopping $1 billion upfront for rights to an Arvinas drug for breast cancer from

Pfizer puts up $1bn to buy into Arvinas breast cancer programme

https://pharmaphorum.com/news/pfizer-puts-up-1bn-to-buy-into-arvinas-breast-cancer-programme/

Join Your Protein Degradation Community

2nd Targeted Protein Degradation

https://pharmaphorum.com/events/2nd-targeted-protein-degradation/

protein degradation